Clinical trials
Completed Phase 3 trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,244 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 10 |
| 2002 | 6 |
| 2003 | 14 |
| 2004 | 25 |
| 2005 | 33 |
| 2006 | 63 |
| 2007 | 68 |
| 2008 | 93 |
| 2009 | 67 |
| 2010 | 98 |
| 2011 | 103 |
| 2012 | 87 |
| 2013 | 82 |
| 2014 | 91 |
| 2015 | 89 |
| 2016 | 66 |
| 2017 | 59 |
| 2018 | 38 |
| 2019 | 42 |
| 2020 | 32 |
| 2021 | 16 |
| 2022 | 22 |
| 2023 | 21 |
| 2024 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,244 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 75 |
| Sanofi | 68 |
| Hoffmann-La Roche | 66 |
| GlaxoSmithKline | 62 |
| Eli Lilly and Company | 60 |
| Novartis Pharmaceuticals | 49 |
| Novo Nordisk A/S | 46 |
| Bristol-Myers Squibb | 40 |
| Pfizer | 38 |
| Boehringer Ingelheim | 33 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 131 |
| Diabetes Mellitus | 53 |
| Pulmonary Disease, Chronic Obstructive | 48 |
| Carcinoma, Non-Small-Cell Lung | 46 |
| Schizophrenia | 46 |
| Asthma | 41 |
| Arthritis, Rheumatoid | 39 |
| Breast Neoplasms | 34 |
| Colitis, Ulcerative | 27 |
| Renal Insufficiency, Chronic | 26 |
Trials
Showing 1 to 25 of 1,244. Each trial links to its page on Pharma Observatory.
1,144 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.